Earnings Call Transcripts

Access detailed transcripts and key takeaways from company earnings calls

All Earnings Calls

GRDN May 6, 2026

Guardian Pharmacy Services Q1 2026 Earnings Call - IRA Transition Holds Firm as EBITDA Guidance Rises

Guardian Pharmacy Services navigated its first full quarter under the Inflation Reduction Act framework with disciplined execution, delivering 2% reported revenue growth and 27% adjusted EBITDA growth...

  • Guardian reported $336.6 million in Q1 2026 revenue, up 2% year-over-year, with management noting that low-double-digit growth would have occurred absent IRA-mandated pricing declines on branded drugs.
  • Adjusted EBITDA surged 27% to $29.8 million, driven by a $3 million one-time discrete benefit from favorable payer dynamics and a manufacturer inventory credit, which management explicitly stated is non-recurring.
  • Full-year adjusted EBITDA guidance was raised to $123-$127 million from $120-$124 million, while revenue guidance remains unchanged at $1.4-$1.42 billion, reflecting confidence in underlying volume growth despite headwinds.
  • +7 more takeaways
FORR May 6, 2026

Forrester Research Q1 2026 Earnings Call - AI Research Pivot Drives Retention Uptick and Raised Revenue Guidance

Forrester Research delivered a mixed Q1 2026 report that underscores a tactical pivot from legacy consulting toward an AI-native research model. Revenue fell 5% year over year to $85.5 million, weighe...

  • Revenue declined 5% year over year to $85.5 million, reflecting broader market softness and the exit from strategy consulting.
  • Research revenue fell just 2%, outperforming the consulting segment, which dropped 13% as Forrester winds down its strategy advisory business.
  • Free cash flow reached $19 million, or $25 million excluding a one-time $5.4 million headquarters capital expenditure.
  • +7 more takeaways
ARAY May 6, 2026

Accuray Q3 FY2026 Earnings Call - Geopolitical Headwinds Force Guidance Withdrawal Amid Transformation Progress

Accuray’s third quarter fiscal 2026 results landed in a geopolitical crossfire. Total revenue came in at $104.8 million, down 7% year-over-year, as shipments to the Middle East, North Africa, and Paki...

  • Total revenue of $104.8 million fell 7% year-over-year and 10% on a constant currency basis, missing expectations due to delayed shipments in the Middle East and North Africa.
  • Accuray withdrew full-year financial guidance, citing indefinite delays in customer installations across the Middle East, North Africa, and Pakistan, as well as persistent volatility in China.
  • Product revenue declined 13% year-over-year to $49.7 million, with China’s macroeconomic headwinds and tariff uncertainty acting as primary drag.
  • +10 more takeaways
AVD May 6, 2026

American Vanguard Q1 2026 Earnings Call - U.S. Crop Surge Drives 245% EBITDA Jump Amid Ag Sector Turmoil

American Vanguard reported a strong first quarter for 2026, with net sales rising 7% to $124 million and adjusted EBITDA surging 245% to $10.3 million. The U.S. crop business was the clear outperforme...

  • U.S. crop sales surged 17% year-over-year, driven by strong volume growth in herbicide and insecticide products, particularly Impact and Aztec.
  • Adjusted EBITDA jumped 245% to $10.3 million, reflecting a 500 basis point expansion in gross margins and improved operating efficiency.
  • International sales declined 7% due to unfavorable comparables and timing delays in Brazil and India, though Central America and Australia showed improvement.
  • +7 more takeaways
RGR May 6, 2026

Sturm, Ruger & Co." Q1 2026 Earnings Call - New Products Drive 41% of Sales as Ruger Beats Market Despite One-Time Costs

Sturm, Ruger & Co. delivered a resilient Q1 2026, with net sales rising 4% to $141 million and diluted earnings of $0.01 per share, though adjusted earnings came in at $0.27 after factoring in $7.4 mi...

  • Net sales rose 4% to $141 million, marking the fourth consecutive quarter of year-over-year top-line growth.
  • Diluted earnings were $0.01 per share, but adjusted earnings came in at $0.27 after excluding $7.4 million in one-time costs.
  • New products accounted for 41% of total firearm sales, generating $51.6 million and driving a 28% increase in units ordered to 525,000.
  • +7 more takeaways
DEI May 6, 2026

Douglas Emmett Q1 2026 Earnings Call - Record Leasing Volume Signals Potential Office Bottom

Douglas Emmett delivered a strong first quarter, driven by record new leasing activity and positive absorption that marks its best results since 2019. The company closed a strategic acquisition of pre...

  • Record New Leasing Volume: Douglas Emmett signed 461,000 square feet of new leases in Q1, the highest quarterly total in company history, signaling robust demand across key industries like legal, financial services, and entertainment.
  • Positive Absorption Continues: The company achieved approximately 100,000 square feet of positive absorption for the second consecutive quarter, delivering its best results since 2019 and growing lease rates by over 1%.
  • Strategic Medical Office Acquisition: Management closed on the $260 million acquisition of The Bedford Collection, a 246,000-square-foot premium medical office portfolio in Beverly Hills, expanding their product mix into sticky, high-quality medical tenants.
  • +7 more takeaways
OXY May 6, 2026

Occidental Petroleum Q1 2026 Earnings Call - Debt Reduction and Leadership Transition Take Center Stage

Occidental Petroleum delivered a strong first quarter in 2026, generating $1.7 billion in free cash flow before working capital and driving principal debt down to $13.3 billion, well below the $14.3 b...

  • CEO Transition: Vicki Hollub retires June 1st; COO Richard Jackson assumes CEO role, signaling continuity in strategy with a focus on execution and cash flow delivery.
  • Debt Reduction Ahead of Schedule: Principal debt fell to $13.3 billion, below the $14.3 billion Q4 target, with a clear near-term goal of reaching $10 billion to strengthen balance sheet flexibility.
  • Record Free Cash Flow: Generated approximately $1.7 billion in free cash flow before working capital in Q1, driven by operational outperformance and higher commodity prices, up 52% year-over-year from continuing operations.
  • +9 more takeaways
CRC May 6, 2026

California Resources Corporation Q1 2026 Earnings Call - Capital Efficiency and Growth Acceleration

California Resources Corporation delivered a strong start to 2026, with Q1 adjusted EBITDA of $304 million, beating guidance by 17%. The company is accelerating its capital program, adding three rigs ...

  • Q1 2026 adjusted EBITDA reached $304 million, approximately 17% above the midpoint of guidance.
  • Full-year adjusted EBITDAX guidance raised by over 40%, outpacing the expected rise in Brent prices.
  • Capital program accelerated with three additional rigs, bringing the total to seven, to drive production growth.
  • +7 more takeaways
RAND May 6, 2026

Rand Capital Corporation Q1 2026 Earnings Call - Dividend Resilience Amidst Portfolio Transition

Rand Capital navigated a transitional first quarter, with investment income down 38% year-over-year as debt repayments from 2025 shrunk the income-producing portfolio. Non-accruals at FSS and MRES fur...

  • Investment income fell 38% to $1.2 million, driven by reduced interest income following the repayment of five debt investments in 2025.
  • Net investment income was $0.18 per share, down from the prior year, as non-accruals at FSS and MRES impacted current yield.
  • The annualized weighted average yield on debt investments dropped to 9.43% from 11.3%, primarily due to the drag from non-accrual positions.
  • +11 more takeaways
BCH May 6, 2026

Banco de Chile Q1 2026 Earnings Call - ROE Guidance Raised Amid Inflation Spike and Geopolitical Uncertainty

Banco de Chile reported a solid first quarter 2026, with net income of CLP 269 billion and an ROE of 18%, driven by disciplined cost control, strong asset quality, and resilient fee generation. The ba...

  • Banco de Chile reported Q1 2026 net income of CLP 269 billion, yielding an ROE of 18% and a ROA of 2%, outperforming peers despite a low-inflation environment.
  • The bank raised its full-year ROE guidance to 21.5%-22.5%, driven by higher expected inflation from a geopolitical supply shock, while maintaining nominal loan growth guidance at 7%.
  • Non-performing loans improved to 1.6%, with a cost of risk of 1.16%, reflecting disciplined credit underwriting and a high-quality customer base.
  • +9 more takeaways